Navigation Links
AVAC Praises Thai AIDS Vaccine Trial Collaborators and Volunteers for Historic Study
Date:9/24/2009

that can be made available to all who need them. There is a great deal of work to be done on many fronts at once, and AVAC is fully committed to hastening that day. We need to enlist a larger number of new vaccine advocates to keep the process moving productively as quickly as feasible," said Bill Snow, an AIDS vaccine activist since 1991, and a co-founder of AVAC in 1995.

There are also still other HIV vaccine strategies in laboratory and human testing. Furthermore, other HIV prevention options, particularly microbicides and pre-exposure prophylaxis, or PrEP, are being tested in efficacy trials which will yield results in the next few years. In the last few years, clinical trials have also shown that medical male circumcision can be effective at reducing the risk of HIV infection in heterosexual men.

"This step adds immensely to the drive for comprehensive HIV prevention," Warren added. "That means perfecting methods and ensuring access for all who need it to existing HIV prevention and treatment options, including male and female condoms, behavior change counseling, male circumcision, clean needles, harm reduction and antiretroviral drugs; ensuring continued research to find effective new options, including vaccines, microbicides, and PrEP; and planning for integrating these new interventions into combination programs."

More information about the Thai trial results is available on the AVAC website at http://www.avac.org/thaitrial.htm. Additional information will be added as it becomes available.

About AVAC: Founded in 1995 as the AIDS Vaccine Advocacy Coalition, AVAC is an international, non-profit organization that uses education, policy analysis, advocacy and community mobilization to accelerate the ethical development and eventual global delivery of AIDS vaccines and other new HIV p
'/>"/>

SOURCE AIDS Vaccine Advocacy Coalition
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. HIV Vaccine Study First to Show Some Effectiveness in Preventing HIV
2. Regence to Cover Administration Costs of H1N1 Vaccine for Fully-Insured Groups, Individuals This Flu Season
3. LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge
4. Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
5. Society of Gynecologic Oncologists Issues White Paper on HPV Vaccines Impact on Cervical Cancer Prevention
6. Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy
7. AlphaVax Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine
8. Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet
9. CEL SCI Collaborators Demonstrate Novel L.E.A.P.S. Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other Influenzas
10. Malaria Vaccine Developer, Sanaria Inc., Receives 2009 Vaccine Industry Excellence Award for Best Early-Stage Vaccine Biotech
11. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... EDGE, N.J. , May 23, 2013 ... a commercial stage medical device company that develops and ... successful completion of its rights offering.  In addition, the ... March 2011 warrants expired on May 17, 2013. ... of $3.0 million from the rights offering.   A portion ...
(Date:5/23/2013)... 2013  TeamHealth Medical Call Center (THMCC), a ... advice lines, announces its newly formed Clinical Advisory ... administrative leaders, provides clinical expertise to advance THMCC,s ... for hospital clients, physician clients and patients. ... it,s imperative to continuously advance our services and ...
(Date:5/23/2013)... MONICA, Calif. , May 23, 2013 ... a program that would have required them to obtain ... today by Consumer Watchdog and Whatley Kallas LLC.  ... Diego Superior Court, alleged that Blue Cross,s mandatory mail ... patients, threatening their health and privacy. "This ...
Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
... -- Metabasis,Therapeutics, Inc. announced today that a poster ... Tolerability and Pharmacokinetics,(PK) of Intravenous (IV) Infusion of ... be presented at,the 2007 annual meeting of the ... CA. The presentation will take,place on April 16, ...
... A study comparing,the formulations of isosorbide dinitrate (ISDN) ... II, and BiDil, the proprietary,fixed dose combination, used ... no bioequivalence. Non-bioequivalence,in the formulations used may explain ... results in decreasing mortality. Using,identical amounts of active ...
Cached Medicine Technology:Metabasis Therapeutics to Present Poster at American Association,for Cancer Research 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 3Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 4Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 5
(Date:5/24/2013)... respected Alzheimer,s researchers failed to replicate what appeared to ... disease when they were published last year in the ... Feb. 9, 2012, suggested that the drug bexarotene (marketed ... amyloid plaques (Aβ) a pathological hallmark of Alzheimer,s ... the authors of the 2012 report, drug treatment quickly ...
(Date:5/24/2013)... Salt Lake City, Utah (PRWEB) May 24, 2013 ... AnatomyOne 2.0 , with exciting new enhancements for instructors ... help students stay more focused through personalize learning plan ... the new AnatomyOne release provides 500 new assessment questions, ... make and review notes. , AnatomyOne 2.0 ...
(Date:5/24/2013)... 24, 2013 Mr. Brian Su, CEO ... Annual EB-5 Investment Summit: Dealmakers Conference in Long Beach, ... focus on exploring alternative finance through EB-5 immigrant investors ... and economic information, and updates to project developers, regional ... industry. , "Our goal is to assist EB-5 ...
(Date:5/24/2013)... York, NY (PRWEB) May 24, 2013 ... Yahoo Commerce VP, Brandon Huff as Executive Vice President ... its commerce business units, which represented a large portion ... lead digital growth as Dwell develops a fully-integrated commerce ... a decade of experience monetizing digital content for leading ...
(Date:5/24/2013)... Stoler believes that there is much to be learned ... That’s why he hosts “Building New York—New York ... that’s why he invited Robert Glazer, Chief Executive Officer ... specialty practice in the greater New York area, whose ... sub-specialists service communities throughout New York and New Jersey ...
Breaking Medicine News(10 mins):Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 3Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California 2Health News:Yahoo Commerce Head Joins Leadership at Dwell Media 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 3Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 4
... funding source to public health , ... Prevention today unveiled health reform recommendations to Congress that ... tackle the chronic diseases that are causing medical costs ... Under these proposals, federally funded insurance programs would provide ...
... Karmanos, Work It Out (DKWIO), a,dynamic 501(c)(3) not-for-profit program ... today announced that Tracey Secco has joined,DKWIO as Director ... ten years,of experience in public relations and program management ... organization,s life-changing message. , ...
... Dec. 11 PURE Bioscience,(Nasdaq: PURE ), ... reported revenues for the fiscal quarter ended October,31, 2008 ... same quarter,last year. The Company reported a loss ... for the current quarter compared with a,loss of $(1,008,700), ...
... beta agonists may cause asthma problems and death, agency ... safety of four asthma medications will be weighed by a ... of hearings end Thursday. , The controversy over these drugs ... officials recently calling for banning the use of these drugs ...
... in Pennsylvania to open store in Mechanicsburg,s , ... CAMP HILL, Pa., Dec. 11 As individuals and seniors ... and small business owners look for health plan options, Highmark ... health insurer in the state to open a health insurance ...
... and founder of Allergy & Asthma Network Mothers of ... access to all forms of 12-hour bronchodilators at a ... Safety and Risk Management Advisory Committee and Pediatric Advisory ... Rockville, MD. , , ...
Cached Medicine News:Health News:Partnership for Prevention Offers Health Reform Recommendations to Congress 2Health News:Partnership for Prevention Offers Health Reform Recommendations to Congress 3Health News:Danialle Karmanos' Work It Out Names Tracey Secco as Director of Operations 2Health News:PURE Bioscience Reports First Quarter Results 2Health News:PURE Bioscience Reports First Quarter Results 3Health News:PURE Bioscience Reports First Quarter Results 4Health News:PURE Bioscience Reports First Quarter Results 5Health News:PURE Bioscience Reports First Quarter Results 6Health News:FDA Panel Mulls Safety of Asthma Meds 2Health News:FDA Panel Mulls Safety of Asthma Meds 3Health News:Highmark Blue Shield to Open 'Highmark Direct,' a Health Insurance Retail Store 2Health News:Highmark Blue Shield to Open 'Highmark Direct,' a Health Insurance Retail Store 3Health News:AANMA Provides Commentary to FDA Advisory Committees Reviewing Benefit-Risk Assessment of 12 Hour Bronchodilators 2
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor...
... German Craftsmanship have produced ... in the world. Ocutek® ... to you! Only holders ... certificate, which requires and ...
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
Medicine Products: